Narayana Hrudayalaya Limited

NSEI:NH Stock Report

Market Cap: ₹259.2b

Narayana Hrudayalaya Valuation

Is NH undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of NH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: NH (₹1261.15) is trading above our estimate of fair value (₹1234.33)

Significantly Below Fair Value: NH is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for NH?

Key metric: As NH is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for NH. This is calculated by dividing NH's market cap by their current earnings.
What is NH's PE Ratio?
PE Ratio32.9x
Earnings₹7.79b
Market Cap₹259.25b

Price to Earnings Ratio vs Peers

How does NH's PE Ratio compare to its peers?

The above table shows the PE ratio for NH vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average67.9x
KIMS Krishna Institute of Medical Sciences
67.4x24.6%₹223.2b
MEDANTA Global Health
59.5x20.2%₹290.3b
RAINBOW Rainbow Children's Medicare
70x23.2%₹162.1b
FORTIS Fortis Healthcare
74.7x26.8%₹489.6b
NH Narayana Hrudayalaya
32.9x13.6%₹256.1b

Price-To-Earnings vs Peers: NH is good value based on its Price-To-Earnings Ratio (32.9x) compared to the peer average (67.9x).

Price to Earnings Ratio vs Industry

How does NH's PE Ratio compare vs other companies in the IN Healthcare Industry?

3 CompaniesPrice / EarningsEstimated GrowthMarket Cap
523696 Fortis Malar Hospitals
2.1xn/aUS$11.79m
516110 Family Care Hospitals
3.3xn/aUS$4.45m
542918 Gian Life Care
5xn/aUS$2.35m
No more companies available in this PE range
NH 32.9xIndustry Avg. 42.3xNo. of Companies6PE020406080100+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: NH is good value based on its Price-To-Earnings Ratio (32.9x) compared to the Indian Healthcare industry average (42.3x).

Price to Earnings Ratio vs Fair Ratio

What is NH's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

NH PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio32.9x
Fair PE Ratio51.7x

Price-To-Earnings vs Fair Ratio: NH is good value based on its Price-To-Earnings Ratio (32.9x) compared to the estimated Fair Price-To-Earnings Ratio (51.6x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst NH forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current₹1,261.15
₹1,382.08
+9.6%
12.4%₹1,650.00₹1,030.00n/a12
Nov ’25₹1,248.20
₹1,364.33
+9.3%
11.9%₹1,600.00₹1,030.00n/a12
Oct ’25₹1,236.90
₹1,369.08
+10.7%
11.4%₹1,600.00₹1,000.00n/a12
Sep ’25₹1,268.95
₹1,396.27
+10.0%
8.2%₹1,600.00₹1,146.00n/a11
Aug ’25₹1,252.75
₹1,379.40
+10.1%
8.2%₹1,558.00₹1,146.00n/a10
Jul ’25₹1,216.10
₹1,379.30
+13.4%
8.3%₹1,558.00₹1,145.00n/a10
Jun ’25₹1,189.25
₹1,366.90
+14.9%
8.2%₹1,558.00₹1,145.00n/a10
May ’25₹1,287.10
₹1,421.70
+10.5%
9.3%₹1,669.00₹1,145.00n/a10
Apr ’25₹1,296.30
₹1,427.67
+10.1%
9.6%₹1,669.00₹1,152.00n/a9
Mar ’25₹1,296.25
₹1,427.67
+10.1%
9.6%₹1,669.00₹1,152.00n/a9
Feb ’25₹1,363.25
₹1,286.33
-5.6%
8.8%₹1,540.00₹1,152.00n/a9
Jan ’25₹1,203.40
₹1,252.11
+4.0%
7.1%₹1,410.00₹1,147.00n/a9
Dec ’24₹1,225.30
₹1,219.50
-0.5%
9.0%₹1,410.00₹990.00n/a10
Nov ’24₹997.65
₹1,111.00
+11.4%
7.2%₹1,280.00₹990.00₹1,248.209
Oct ’24₹1,085.50
₹1,106.50
+1.9%
7.6%₹1,280.00₹990.00₹1,236.908
Sep ’24₹1,024.25
₹1,100.88
+7.5%
8.0%₹1,280.00₹990.00₹1,268.958
Aug ’24₹1,014.90
₹989.25
-2.5%
6.6%₹1,100.00₹885.00₹1,252.758
Jul ’24₹993.25
₹989.25
-0.4%
6.6%₹1,100.00₹885.00₹1,216.108
Jun ’24₹910.60
₹938.78
+3.1%
7.3%₹1,019.00₹789.00₹1,189.259
May ’24₹761.85
₹877.63
+15.2%
7.4%₹976.00₹789.00₹1,287.108
Apr ’24₹774.15
₹877.63
+13.4%
7.4%₹976.00₹789.00₹1,296.308
Mar ’24₹742.90
₹872.86
+17.5%
7.9%₹976.00₹789.00₹1,296.257
Feb ’24₹712.15
₹816.86
+14.7%
8.1%₹920.00₹708.00₹1,363.257
Jan ’24₹760.45
₹816.86
+7.4%
8.1%₹920.00₹708.00₹1,203.407
Dec ’23₹753.10
₹814.00
+8.1%
7.6%₹900.00₹708.00₹1,225.307
Nov ’23₹770.95
₹769.00
-0.3%
5.9%₹820.00₹700.00₹997.657

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Yatharth Hospital & Trauma Care Services

₹52.3b

Owns and operates super-specialty hospitals in Delhi and Madhya Pradesh.

543950

₹605.65

7D

-1.1%

1Y

55.5%

N G Industries

₹561.9m

Provides various healthcare services in India.

530897

₹162.40

7D

-0.6%

1Y

-6.1%

Dr Lalchandani Labs

₹78.0m

Provides diagnostic and related healthcare tests and services in India.

541299

₹17.15

7D

-4.7%

1Y

-51.0%